News Juno halts CAR-T trial again after 2 more deaths Doubts over Juno CAR-T therapy after two more trial deaths.
News Alnylam plunges after deaths in rare disease trial Biotech axes revusiran due to safety concerns.
News Sandoz, Teva and Mylan generics to be suspended in EU Regulator concerned over data from contract research organisation.
News Patients may have quit statins after media row Coverage may have given "disproportional weight" to concerns over side effects.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.